Phase II trial of capecitabine plus cisplatin as first-line therapy in patients with metastatic nasopharyngeal cancer

Head & Neck ◽  
2011 ◽  
Vol 34 (9) ◽  
pp. 1225-1230 ◽  
Author(s):  
Daniel T. T. Chua ◽  
Harry Ho-Yin Yiu ◽  
Kasan Seetalarom ◽  
Alice Wan-Ying Ng ◽  
Johan Kurnianda ◽  
...  
Keyword(s):  
Phase Ii ◽  
Phase Ii Trial ◽  
Nasopharyngeal Cancer ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

672 Randomised phase II trial (M77001) of trastuzumab (Herceptin®) plus docetaxel versus docetaxel alone, as first-line therapy in patients with HER2-positive metastitic breast cancer

2003 ◽  
Vol 1 (5) ◽  
pp. S202 ◽  
Author(s):  
J.-M. Extra ◽  
F. Cognetti ◽  
S. Chan ◽  
D. Maraninchi ◽  
R. Snyder ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
First Line ◽  
Her2 Positive ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals Randomized, Multi-center Phase II Trial of Docetaxel Plus Cisplatin Versus Etoposide Plus Cisplatin as the First-line Therapy for Patients with Advanced Non-Small Cell Lung Cancer

2005 ◽  
Vol 37 (6) ◽  
pp. 332
Author(s):  
Nam-Su Lee ◽  
Hee-Sook Park ◽  
Jong-Ho Won ◽  
Dae-Sik Hong ◽  
Su-Taek Uh ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Phase II Trial of Weekly Vinorelbine and Trastuzumab as First‐Line Therapy in Patients with HER2 + Metastatic Breast Cancer

2002 ◽  
Vol 7 (5) ◽  
pp. 410-417 ◽  
Author(s):  
Mohammad Jahanzeb ◽  
Joanne E. Mortimer ◽  
Furhan Yunus ◽  
David H. Irwin ◽  
James Speyer ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Metastatic Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Metastatic Breast ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Phase II Trial of Irinotecan plus Cisplatin Combination as First Line Therapy for Patients with Small cell Lung Cancer

2006 ◽  
Vol 60 (1) ◽  
pp. 57 ◽  
Author(s):  
Hye Cheol Jeong ◽  
Sang Yeub Lee ◽  
Jung Ha Kim ◽  
Eun Sil Ha ◽  
Jin Yong Jung ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

scholarly journals Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD+C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS

2012 ◽  
Vol 23 (6) ◽  
pp. 1555-1561 ◽  
Author(s):  
R. Houot ◽  
S. Le Gouill ◽  
M. Ojeda Uribe ◽  
C. Mounier ◽  
S. Courby ◽  
...  
Keyword(s):  
Mantle Cell Lymphoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Cell Lymphoma ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy ◽  
Mantle Cell

Adjuvant chemotherapy with temozolomide and pegylated liposomal doxorubicin in the first-line therapy of patients with glioblastoma -a phase-II trial

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 1547-1547
Author(s):  
P. Hau ◽  
T. Jauch ◽  
B. Hirschmann ◽  
E. Drechsel ◽  
O. Grauer ◽  
...  
Keyword(s):  
Adjuvant Chemotherapy ◽  
Phase Ii ◽  
Liposomal Doxorubicin ◽  
Phase Ii Trial ◽  
Pegylated Liposomal Doxorubicin ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy

Phase II trial of docetaxel and gefitinib as first-line therapy for elderly patients with advanced non-small cell lung cancer (ANSCLC)

2004 ◽  
Vol 22 (14_suppl) ◽  
pp. 7342-7342
Author(s):  
C. C. Williams ◽  
E. B. Haura ◽  
S. J. Antonia ◽  
A. Chiappori ◽  
G. Bepler ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Elderly Patients ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Small Cell ◽  
Small Cell Lung ◽  
First Line ◽  
First Line Therapy ◽  
Line Therapy
Sign in / Sign up

Export Citation Format

Share Document